ZILUCOPLAN, A MACROCYCLIC PEPTIDE INHIBITOR OF COMPLEMENT COMPONENT 5 (C5), DEMONSTRATES MECHANISTIC AND PHARMACOLOGICAL DIFFERENTIATION FROM ANTI-C5 MONOCLONAL ANTIBODIES

Ricardo, A; Hoarty, M; DeMarco, S; Duda, P; Farzaneh-Far, R; Ma, Z; Read, S; Sayegh, C; Tang, GQ; Thackaberry, E; Vadysirisack, D; Zhu, NQ

MUSCLE & NERVE, 2019; 60 (): S50